Equine rhinitis A virus-like particle expressing DNA vaccine induces a virus neutralising immune response in mice

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 294-297

  Lynch, Stacey E ^a   Gilkerson, James R ^a   Symes, Sally J ^a   Huang, Jin an ^b   Tatarczuch, Liliana ^a   Hartley, Carol A ^a  

^a The University of Melbourne   (Australia)

^b Pfizer Australia   (Australia)

Author keywords

Equine rhinitis A virus; Virus like particles

Indexed keywords

CAPSID PROTEIN; DNA VACCINE; NEUTRALIZING ANTIBODY; PLASMID VECTOR; PROTEINASE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; EQUINE RHINITIS A VIRUS; FEMALE; GENE CONSTRUCT; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VIRUS CAPSID; VIRUS LIKE AGENT; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; APHTHOVIRUS; CAPSID PROTEINS; CYTOMEGALOVIRUS; FEMALE; MICE; MICE, INBRED BALB C; PEPTIDE HYDROLASES; PLASMIDS; VACCINES, DNA; VACCINES, VIROSOME;

CYTOMEGALOVIRUS; EQUIDAE; EQUINE RHINITIS A VIRUS; MIRIDAE; MUS;

EID: 79956296796     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.04.009     Document Type: Article

References (23)

1. Abrams C.C., King A.M., Belsham G.J. Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system. J. Gen. Virol. 1995, 76(Pt 12):3089-3098.
2. Bell S.A., Balasuriya U.B.R., Gardner I.A., Barry P.A., Wilson W.D., Ferraro G.L., MacLachlan N.J. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Vet. Microbiol. 2006, 116(4):249-257.
3. Burrows R. Equine rhinoviruses. Equine Infectious Diseases II: Proceedings of the 2nd International Conference on Equine Infectious Disease 1970, 154-164. Karger, Basel, Switzerland. J.T. Bryans, H. Gerber (Eds.).
4. Carman S., Rosendal S., Huber L., Gyles C., McKee S., Willoughby R.A., Dubovi E., Thorsen J., Lein D. Infectious agents in acute respiratory disease in horses in Ontario. J. Vet. Diagn. Invest. 1997, 9(1):17-23.
5. Chung Y.C., Huang J.H., Lai C.W., Sheng H.C., Shih S.R., Ho M.S., Hu Y.C. Expression, purification and characterization of enterovirus-71 virus-like particles. World J. Gastroenterol. 2006, 12(6):921-927.
6. Fry E.E., Tuthill T.J., Harlos K., Walter T.S., Rowlands D.J., Stuart D.I. The crystal structure of Equine rhinitis A virus in complex with its sialic acid receptor. J. Gen. Virol. 2010, 91:1971-1977.
7. Hartley C.A., Ficorilli N., Dynon K., Drummer H.E., Huang J.A., Studdert M.J. Equine rhinitis A virus: structural proteins and immune response. J. Gen. Virol. 2001, 82(Pt 7):1725-1728.
8. Horton R.M., Ho S.N., Pullen J.K., Hunt H.D., Cai Z., Pease L.R. Gene splicing by overlap extension. Methods Enzymol. 1993, 217:270-279.
9. Jeoung H.Y., Lee W.H., Jeong W., Ko Y.J., Choi C.U., An D.J. Immune responses and expression of the virus-like particle antigen of the porcine encephalomyocarditis virus. Res. Vet. Sci. 2010, 89(2):295-300.
10. Jin H., Kang Y., Xiao C., Zhu K., Ma Y., Xie Q., Ma J., He C., Yang Z., Sun Z., Zhang X., Chen M., Zhang F., Wang B. DNA prime followed by protein boost enhances neutralization and Th1 type immunity against FMDV. Viral Immunol. 2005, 18(3):539-548.
11. Kriegshauser G., Kuechler E., Skern T. Aggregation-associated loss of antigenicity observed for denatured virion protein 1 of Equine rhinitis A virus in an enzyme-linked immunosorbent assay. Virus Res. 2009, 143(1):130-133.
12. Kriegshauser G., Wutz G., Lea S., Stuart D., Skern T., Kuechler E. Model of the equine rhinitis A virus capsid: identification of a major neutralizing immunogenic site. J. Gen. Virol. 2003, 84(Pt 9):2365-2373.
13. Lewis S.A., Morgan D.O., Grubman M.J. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 1991, 65(12):6572-6580.
14. Li F., Drummer H.E., Ficorilli N., Studdert M.J., Crabb B.S. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses. J. Clin. Microbiol. 1997, 35(4):937-943.
15. Li F., Stevenson R.A., Crabb B.S., Studdert M.J., Hartley C.A. Several recombinant capsid proteins of equine rhinitis a virus show potential as diagnostic antigens. Clin. Diagn. Lab. Immunol. 2005, 12(6):778-785.
16. Mateu M.G., Camarero J.A., Giralt E., Andreu D., Domingo E. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 1995, 206(1):298-306.
17. Racaniello V.R. Picornaviridae: the viruses and their replication. Fields Virology 2007, 795-838. Lippincott, Williams and Wilkins. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
18. Rombaut B., Jore J.P.M. Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae. J. Gen. Virol. 1997, 78:1829-1832.
19. Stevenson R.A., Hartley C.A., Huang J.A., Studdert M.J., Crabb B.S., Warner S. Mapping epitopes in equine rhinitis A virus VP1 recognized by antibodies elicited in response to infection of the natural host. J. Gen. Virol. 2003, 84(Pt 6):1607-1612.
20. Stevenson R.A., Huang J.A., Studdert M.J., Hartley C.A. Identification of a neutralizing epitope in the betaE-betaF loop of VP1 of equine rhinitis A virus, defined by a neutralization-resistant variant. J. Gen. Virol. 2004, 85(Pt 9):2545-2553.
21. Studdert M.J., Gleeson L.J. Isolation and characterisation of an equine rhinovirus. Zentralbl Veterinarmed B 1978, 25(3):225-237.
22. Tuthill T.J., Harlos K., Walter T.S., Knowles N.J., Groppelli E., Rowlands D.J., Stuart D.I., Fry E.E. Equine rhinitis A virus and its low pH empty particle: clues towards an aphthovirus entry mechanism?. PLoS Pathog. 2009, 5(10). e1000620, ePub 2009 October 9.
23. Warner S., Hartley C.A., Stevenson R.A., Ficorilli N., Varrasso A., Studdert M.J., Crabb B.S. Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding. J. Virol. 2001, 75(19):9274-9281.